Department of Medicine, Cedars-Sinai Medical Center, 8635 West Third Street, Suite 1060, Los Angeles, CA 90048, USA.
Clin Liver Dis. 2012 Feb;16(1):73-89. doi: 10.1016/j.cld.2011.12.007.
Hepatic encephalopathy (HE) is a potentially reversible state of impaired cognitive function or altered consciousness in patients with liver disease or portosystemic shunting. Overt HE is a particularly pressing problem. Given the many targets of treatment and lack of a clear singular cause of overt HE, there is no consensus on a single best treatment. Over the past several years, high-quality studies have been conducted on the various pharmacologic therapies for HE and, as more data emerge, hopefully HE will become a much more easily treated complication of decompensated liver disease.
肝性脑病(HE)是一种潜在可逆的认知功能障碍或意识改变状态,发生于肝脏疾病或门体分流患者。显性肝性脑病是一个特别紧迫的问题。鉴于治疗靶点众多,且显性肝性脑病的单一病因并不明确,因此针对该病,尚无单一最佳治疗方法的共识。在过去几年中,已经对 HE 的各种药物治疗进行了高质量的研究,随着更多数据的出现,希望 HE 能够成为失代偿性肝病更易于治疗的并发症。